Scarica l'app Stockscreener
6.03
0.99%
-0.06
Dopo l'orario di chiusura:
6.08
0.05
+0.83%
Precedente Chiudi:
$6.09
Aprire:
$6.08
Volume 24 ore:
453.42K
Relative Volume:
1.04
Capitalizzazione di mercato:
$356.22M
Reddito:
-
Utile/perdita netta:
$-153.16M
Rapporto P/E:
-1.6341
EPS:
-3.69
Flusso di cassa netto:
$-134.48M
1 W Prestazione:
+1.69%
1M Prestazione:
-26.37%
6M Prestazione:
-29.39%
1 anno Prestazione:
-65.84%
Intervallo 1D:
$6.02
$6.26
Intervallo di 1 settimana:
$6.01
$6.63
Portata 52W:
$5.89
$18.40
Cullinan Therapeutics Inc Stock (CGEM) Company Profile
Nome
Cullinan Therapeutics Inc
Settore
Industria
Telefono
617-410-4650
Indirizzo
ONE MAIN STREET, CAMBRIDGE
Confronta CGEM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CGEM
Cullinan Therapeutics Inc
|
6.03 | 359.76M | 0 | -153.16M | -134.48M | -3.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.62 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.98 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.37 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
729.76 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
329.84 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Cullinan Therapeutics Inc Stock (CGEM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-21 | Ripresa | H.C. Wainwright | Buy |
| 2025-06-11 | Ripresa | Stifel | Buy |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-05-01 | Iniziato | Stifel | Buy |
| 2024-04-15 | Iniziato | William Blair | Outperform |
| 2024-02-15 | Iniziato | Wedbush | Outperform |
| 2023-06-15 | Iniziato | TD Cowen | Outperform |
| 2022-11-21 | Iniziato | BTIG Research | Buy |
| 2021-04-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-02-02 | Iniziato | Evercore ISI | Outperform |
| 2021-02-02 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-02-02 | Iniziato | SVB Leerink | Outperform |
| 2021-02-01 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Cullinan Therapeutics Inc Borsa (CGEM) Ultime notizie
Cullinan Therapeutics, Inc. $CGEM Shares Bought by Rhumbline Advisers - Defense World
Using R and stats models for Cullinan Therapeutics Inc. forecastingLong Setup & Entry Point Confirmation Signals - newser.com
BDTX vs. Cullinan Therapeutic: Which EGFR Challenger Is the Better Buy? - sharewise.com
How to use a screener to detect Cullinan Therapeutics Inc. breakoutsEarnings Risk Summary & Real-Time Price Movement Reports - newser.com
Cullinan Therapeutics (NASDAQ:CGEM) Raised to Hold at Zacks Research - MarketBeat
Published on: 2025-09-22 14:30:54 - newser.com
Cullinan Therapeutics Hits New 52-Week Low at $6.32 - Markets Mojo
Reversal indicators forming on Cullinan Therapeutics Inc. stockTreasury Yields & Technical Analysis for Trade Confirmation - newser.com
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives $26.00 Consensus Price Target from Analysts - MarketBeat
Cullinan Therapeutics Hits New 52-Week Low at $5.89 - Markets Mojo
Cullinan Therapeutics Hits New 52-Week Low at $6.24 Amidst Major Decline - Markets Mojo
using r and stats models for cullinan therapeutics inc. forecastingTrade Volume Report & Weekly Market Pulse Updates - newser.com
Best data tools to analyze Cullinan Therapeutics Inc. stock2025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - newser.com
Can Cullinan Therapeutics Inc withstand a market correctionJuly 2025 News Drivers & Long-Term Growth Plans - خودرو بانک
Can technical indicators confirm Cullinan Therapeutics Inc.’s reversalInsider Selling & Daily Chart Pattern Signal Reports - newser.com
Breakouts Watch: Can Cullinan Therapeutics Inc outperform under higher oil prices2025 Historical Comparison & Weekly High Return Stock Forecasts - خودرو بانک
Downgrade Watch: What is the Moat Score of Cullinan Therapeutics Inc2025 Major Catalysts & Technical Pattern Recognition Alerts - khodrobank.com
New Highs: Is Cullinan Therapeutics Inc benefiting from innovation trends2025 Performance Recap & Smart Investment Allocation Tips - خودرو بانک
Published on: 2025-09-20 04:22:55 - خودرو بانک
Is Cullinan Therapeutics Inc. still worth holding after the dipPortfolio Performance Summary & Community Trade Idea Sharing - newser.com
Pullback Watch: Will Cullinan Therapeutics Inc. benefit from government policy2025 Market Sentiment & Stock Timing and Entry Methods - خودرو بانک
Analyzing recovery setups for Cullinan Therapeutics Inc. investors2025 Technical Overview & Real-Time Market Sentiment Alerts - newser.com
Market Pulse: Is DBVT subject to activist investor interest2025 Macro Impact & AI Driven Price Forecasts - khodrobank.com
Aug Chart Watch: Whats the RSI of Cullinan Therapeutics Inc stockQuarterly Growth Report & Fast Moving Stock Watchlists - خودرو بانک
Multi asset correlation models including Cullinan Therapeutics Inc.2025 Earnings Impact & Reliable Trade Execution Plans - newser.com
Performance Recap: What is Cullinan Therapeutics Incs valuation compared to sectorMarket Performance Recap & High Return Stock Watch Alerts - khodrobank.com
Cullinan Therapeutics (NASDAQ:CGEM) Upgraded at Zacks Research - Defense World
Sentiment Recap: Does Cullinan Therapeutics Inc have strong EBITDA margins2025 Technical Overview & Weekly High Conviction Trade Ideas - خودرو بانک
Aug Update: Will Cullinan Therapeutics Inc benefit from seasonalityMarket Growth Review & Reliable Entry Point Trade Alerts - خودرو بانک
Has Cullinan Therapeutics Inc. formed a bullish divergencePortfolio Performance Summary & Community Trade Idea Sharing - newser.com
HC Wainwright Reiterates Buy Rating for Cullinan Therapeutics (NASDAQ:CGEM) - MarketBeat
Will Cullinan Therapeutics Inc. outperform the marketMarket Trend Report & Fast Moving Stock Trade Plans - newser.com
Cullinan Therapeutics, Inc. $CGEM Shares Sold by Goldman Sachs Group Inc. - Defense World
How to monitor Cullinan Therapeutics Inc. with trend dashboardsTrade Ideas & Daily Price Action Insights - newser.com
Cullinan Therapeutics (NASDAQ:CGEM) Given Buy Rating at BTIG Research - MarketBeat
How moving averages guide Cullinan Therapeutics Inc. tradingJobs Report & Momentum Based Trading Signals - newser.com
Retail Surge: What drives Cullinan Therapeutics Incs stock priceJuly 2025 Sector Moves & Intraday High Probability Setup Alerts - khodrobank.com
Portfolio Recap: What is the Moat Score of Cullinan Therapeutics IncWeekly Profit Analysis & Verified Technical Signals - خودرو بانک
Rate Cut: Is Cullinan Therapeutics Inc benefiting from innovation trendsEarnings Growth Summary & Real-Time Market Sentiment Alerts - khodrobank.com
Quarterly Risk: What is the long term forecast for Cullinan Therapeutics Inc stockPortfolio Update Summary & Community Trade Idea Sharing - خودرو بانک
Insider Buy: Can Cullinan Therapeutics Inc outperform under higher oil pricesPortfolio Performance Report & Low Risk Entry Point Tips - khodrobank.com
Support Test: What is the Moat Score of Artisan Partners Asset Management IncJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - خودرو بانک
Taiho Oncology and Cullinan Therapeutics Announce Acceptance of Abstracts for Zipalertinib at the IASLC 2025 World Conference on Lung Cancer - Nasdaq
Can Cullinan Therapeutics Inc. withstand a market correctionSwing Trade & Stepwise Entry and Exit Trade Signals - خودرو بانک
HC Wainwright Reaffirms Buy Rating for Cullinan Therapeutics (NASDAQ:CGEM) - Defense World
Cullinan Therapeutics Inc Azioni (CGEM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.30%
2.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):